Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Valeant Pharms. Int’l Inc. v. Mylan Pharms., Inc., 16-0035 (D.N.J.) Jan. 4, 2016 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide injection)
8,247,425
8,420,663
8,552,025
8,822,490
Otsuka Pharm. Co., Ltd. v. Indoco Remedies Ltd., 16-0086 (D.N.J.) Jan. 7, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Jazz Pharms., Inc. v. Wockhardt Bio AG, 16-0099 (D.N.J.) Jan. 7, 2016 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,050,302
Alcon Pharms. Ltd. v. Watson Labs., Inc., 16-0101 (D.N.J.) Jan. 7, 2016 Hon. Peter G. Sheridan Ciprodex® (ciprofloxacin / dexamethasone otic suspension)
6,284,804
6,359,016
Helsinn Healthcare S.A. v. Sagent Pharms., Inc., 16-0173 (D.N.J.) Jan. 11, 2016 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Prostrakan, Inc. v. Actavis Labs. UT, Inc., 16-0044 (E.D. Tex.) Jan. 13, 2016 Hon. Robert W. Schroeder, III Sancuso® (granisetron extended-release transdermal film) 7,608,282
Prostrakan, Inc. v. Actavis Labs. UT, Inc., 16-0015 (D. Del.) Jan. 15, 2016 Hon. Leonard P. Stark Sancuso® (granisetron extended-release transdermal film) 7,608,282
Hospira, Inc. v. Fresenius Kabi USA, LLC, 16-0651 (N.D. Ill.) Jan. 15, 2016 Hon. Rebecca R. Pallmeyer Precedex® (dexmedetomidine hydrochloride injection)
8,242,158
8,338,470
8,455,527
8,648,106
Rosellini Scientific, LLC v. Grunenthal Gmbh, IPR2016-00471 (PTAB) Jan. 15, 2016 N/A
Nucynta® (tapentadol hydrochloride tablets)

Nucynta® ER (tapentadol hydrochloride extended-release tablets)

Nucynta® (tapentadol hydrochloride solution)
7,994,364
Purdue Pharma L.P. v. Abhai, LLC, 16-0025 (D. Del.) Jan. 19, 2016 Hon. Sue L. Robinson OxyContin® (oxycodone hydrochloride extended-release tablets)
7,674,799
7,674,800
7,683,072
8,114,383
8,309,060
8,337,888
8,808,741
8,894,987
8,894,988
9,060,976
9,073,933
Purdue Pharma L.P. v. Alvogen Pine Brook, LLC, 16-0026 (D. Del.) Jan. 20, 2016 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,198,863
9,205,056
Cubist Pharms. LLC v. Dr. Reddy’s Labs., Ltd., 16-0030 (D. Del.) Jan. 21, 2016 Hon. Gregory M. Sleet Cubicin® (daptomycin for injection)
6,468,967
6,852,689
8,058,238
8,129,342
Purdue Pharma L.P. v. Abhai, LLC, 16-0058 (M.D. Fla.) Jan. 21, 2016 Hon. Timothy J. Corrigan OxyContin® (oxycodone hydrochloride extended-release tablets)
7,674,799
7,674,800
7,683,072
8,114,383
8,309,060
8,337,888
8,808,741
8,894,987
8,894,988
9,060,976
9,073,933
Cubist Pharms. LLC v. Dr. Reddy’s Labs., Ltd., 16-0372 (D.N.J.) Jan. 21, 2016 Hon. Freda L. Wolfson Cubicin® (daptomycin for injection)
6,468,967
6,852,689
8,058,238
8,129,342
Millennium Pharms., Inc. v. Wockhardt Bio AG, 16-0034 (D. Del.) Jan. 22, 2016 Hon. Gregory M. Sleet Velcade® (bortezomib for injection)
6,713,446
6,958,319
Otsuka Pharm. Co., Ltd. v. Orchid Pharma Ltd., 16-0405 (D.N.J.) Jan. 22, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets)
8,017,615
8,580,796
8,642,760
8,518,421
Otsuka Pharm. Co., Ltd. v. Orchid Pharma Ltd., 16-0424 (D.N.J.) Jan. 25, 2015 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Horizon Pharma, Inc. v. Actavis Labs. FL, Inc., 16-0426 (D.N.J.) Jan. 25, 2016 Hon. Mary L. Cooper Vimovo® (naproxen / esomeprazole magnesium delayed-release tablets)
9,161,920
9,198,888
Novartis Pharms. Corp. v. Wockhardt Bio AG, 16-0040 (D. Del.) Jan. 26, 2016 Hon. Leonard P. Stark Gleevec® (imatinib mesylate tablets)
6,894,051
RE43,932
Jazz Pharms., Inc. v. Roxane Labs., Inc., 16-0469 (D.N.J.) Jan. 27, 2016 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,050,302
Mylan Pharms. Inc. v. UCB Pharma Gmbh, IPR2016-00510 (PTAB) Jan. 28, 2016 N/A Toviaz® (fesoterodine fumarate extended-release tablets) 6,858,650
Mylan Pharms. Inc. v. UCB Pharma Gmbh, IPR2016-00512 (PTAB) Jan. 28, 2016 N/A Toviaz® (fesoterodine fumarate extended-release tablets) 7,384,980
Mylan Pharms. Inc. v. UCB Pharma Gmbh, IPR2016-00514 (PTAB) Jan. 28, 2016 N/A Toviaz® (fesoterodine fumarate extended-release tablets) 7,855,230
Mylan Pharms. Inc. v. UCB Pharma Gmbh, IPR2016-00516 (PTAB) Jan. 28, 2016 N/A Toviaz® (fesoterodine fumarate extended-release tablets) 8,338,478
Mylan Pharms. Inc. v. UCB Pharma Gmbh, IPR2016-00517 (PTAB) Jan. 28, 2016 N/A Toviaz® (fesoterodine fumarate extended-release tablets) 7,985,772
Otsuka Pharm. Co., Ltd. v. Stason Industrial Corp., 16-0555 (D.N.J.) Feb. 1, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,089,567
Otsuka Pharm. Co., Ltd. v. Stason Industrial Corp., 16-0557 (D.N.J.) Feb. 1, 2016 Hon. Jerome B. Simandle Abilify® (aripiprazole tablets) 9,125,939
Orexo AB v. Actavis Elizabeth LLC, 16-0062 (D. Del.) Feb. 2, 2016 Hon. Sue L. Robinson Zubsolv® (buprenorphine hydrochloride / naloxone hydrochloride dihydrate sublingual tablets)
8,454,996
8,940,330
The Medicines Co. v. Eagles Pharms., Inc., 16-569 (D.N.J.) Feb. 2, 2016 Hon. Stanley R. Chesler Angiomax® (bivalirudin for injection)
7,713,928
7,803,762
Argentum Pharms. LLC v. Alcon Research, Ltd., IPR2016-00544 (PTAB) Feb. 2, 2016 N/A Pazio® (olopatadine hydrochloride ophthalmic solution) 8,791,154
Amneal Pharms. LLC v. Jazz Pharms., Inc., IPR2016-00546 (PTAB) Feb. 2, 2016 N/A Xyrem® (sodium oxybate oral solution) 8,772,306
Lupin Ltd. v. Vertex Pharms., Inc., IPR2016-00558 (PTAB) Feb. 3, 2016 N/A Lexiva® (fosamprenavir calcium) 6,436,989
Bayer Intellectual Property Gmbh v. Invagen Pharms., Inc., 16-0064 (D. Del.) Feb. 4, 2016 Hon. Sue L. Robinson Xarelto® (rivaroxaban tablets)
7,157,456
7,585,860
7,592,339
Eli Lilly and Co. v. Dr. Reddy’s Labs., Ltd., 16-0308 (S.D. Ind.) Feb. 5, 2016 Hon. Jane Magnus-Stinson Alimta® (pemetrexed disodium injection) 7,772,209
Horizon Pharma Ireland Ltd. v. Actavis Labs. UT, Inc., 16-0645 (D.N.J.) Feb. 5, 2016 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,220,784
Horizon Pharma Ireland Ltd. v. Amneal Pharms. LLC, 16-0646 (D.N.J.) Feb. 5, 2016 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,220,784
Horizon Pharma Ireland Ltd. v. Teligent, Inc., 16-0647 (D.N.J.) Feb. 5, 2016 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,220,784
Horizon Pharma Ireland Ltd. v. Lupin Ltd., 16-0732 (D.N.J.) Feb. 5, 2016 Hon. Noel L. Hillman Pennsaid® (diclofenac sodium topical solution) 9,220,784
Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., PGR2016-00007 (PTAB) Feb. 5, 2016 N/A Aloxi® (palonosetron hydrochloride for injection) 9,173,942
Dr. Reddy’s Labs., Ltd. v. Helsinn Healthcare S.A., PGR2016-00008 (PTAB) Feb. 5, 2016 N/A Aloxi® (palonosetron hydrochloride for injection) 9,173,942
Helsinn Healthcare S.A. v. Sagent Pharms., Inc., 16-0681 (D.N.J.) Feb. 8, 2016 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection)
7,947,724
7,947,725
7,960,424
8,598,219
8,729,094
Cubist Pharms. LLC v. Crane Pharms. LLC, 16-0072 (D. Del.) Feb. 10, 2016 Hon. Gregory M. Sleet Cubicin® (daptomycin for injection)
6,468,967
6,852,689
8,058,238
8,129,342
Bristol-Myers Squibb Co. v. Cipla USA, Inc., 16-0074 (D. Del.) Feb. 11, 2016 Hon. Leonard P. Stark Reyataz® (atazanavir sulfate capsules) 6,087,383
Pfizer Inc. v. Accord Healthcare, Inc., 16-0079 (D. Del.) Feb. 11, 2016 Hon. Sue L. Robinson Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
8,975,242
Pfizer Inc. v. Accord Healthcare, Inc., 16-0113 (M.D.N.C.) Feb. 12, 2016 Hon. Thomas D. Schroeder Tygacil® (tigecycline injectable IV infusion)
7,879,828
8,372,995
8,975,242
Purdue Pharma L.P. v. Epic Pharma, LLC, 16-0087 (D. Del.) Feb. 16, 2016 Hon. Sue L. Robinson OxyContin® (oxycodone hydrochloride extended-release tablets) 9,073,933
AstraZeneca Pharms. LP v. Innopharma, Inc., 16-0894 (D.N.J.) Feb. 16, 2016 Hon. Renee Marie Bumb Faslodex® (fulvestrant injection)
6,774,122
7,456,160
8,329,680
8,466,139
Mylan Pharms. Inc. v. Yeda Research * Development Co., Ltd., PGR2016-00010 (PTAB) Feb. 16, 2016 N/A Copaxone® (glatiramer acetate injection) 9,155,776
Boehringer Ingelheim Pharms. Inc. v. Prinston Pharm. Inc., 16-0851 (D.N.J.) Feb. 17, 2016 Hon. Peter G. Sheridan Jentadueto® (linagliptin / metformin hydrochloride tablets)
8,673,927
8,846,695
Boehringer Ingelheim Pharms. Inc. v. Accord Healthcare, Inc., 16-0852 (D.N.J.) Feb. 17, 2016 Hon. Peter G. Sheridan Jentadueto® (linagliptin / metformin hydrochloride tablets) 9,173,859
Par Pharm., Inc. v. Novartis AG, IPR2016-00078 (PTAB) Oct. 26, 2015 N/A Zortress® (everolimus tablets) 6,455,518
Par Pharm., Inc. v. Novartis AG, IPR2016-00084 (PTAB) Oct. 26, 2015 N/A Zortress® (everolimus tablets) 5,665,772
Complex Innovations, LLC v. Amgen Inc., IPR2016-00085 (PTAB) Oct. 26, 2015 N/A Sensipar® (cinacalcet hydrochloride tablets) 7,829,595
Mylan Labs. Ltd. v. Aventis Pharma S.A., IPR2016-00627 (PTAB) Feb. 17, 2016 N/A Jevtana® Kit (cabazitaxel solution for infusion) 5,847,170
Valeant Pharms. Int’l, Inc. v. Actavis LLC, 16-0889 (D.N.J.) Feb. 18, 2016 Hon. Stanley R. Chesler Relistor® (methylnaltrexone bromide injection)
8,247,425
8,420,663
8,552,025
8,822,490
9,180,125
Merck Sharp & Dohme Corp. v. Par Sterile Products, LLC, 16-0948 (D.N.J.) Feb. 19, 2016 Hon. Peter G. Sheridan Noxafil® (posaconazole solution for infusion) 9,023,790
Sandoz Inc. v. Daiichi Sankyo, Inc., 16-0994 (D.N.J.) Feb. 22, 2016 Hon. Renee Marie Bumb Benicar® (olmesartan medoxomil tablets) 6,878,703
Biomarin Pharm. Inc. v. Par Pharm., Inc., 16-1015 (D.N.J.) Feb. 22, 2016 Hon. Michael A. Shipp Kuvan® (sapropterin dihydrochloride packets)
7,566,714
7,612,073
8,067,416
RE43,797
Frontier Therapeutics, LLC v. medac Gesellschaft für klinische Spezialpräparate mbH, IPR2016-00649 (PTAB) Feb. 22, 2016 N/A Rasuvo® (methotrexate solution) 8,664,231
Sandoz Inc. v. Daiichi Sankyo, Inc., 16-0081 (E.D. Va.) Feb. 22, 2016 Hon. Arenda L. Wright Allen Benicar® (olmesartan medoxomil tablets) 6,878,703
Janssen Products, L.P. v. Lupin Ltd., 16-1032 (D.N.J.) Feb. 23, 2016 Hon. William H. Walls Prezista® (darunavir tablets)
8,518,987
7,126,015
Mylan Pharms., Inc. v. Senju Pharm. Co., Ltd., IPR2016-00626 (PTAB) Feb. 25, 2016 N/A Bepreve® (bepotastine besilate ophthalmic solution) 8,784,789
Eli Lilly and Co. v. Biocon Ltd., 16-0469 (S.D. Ind.) Feb. 26, 2016 Hon. Tanya Walton Pratt Alimta® (pemetrexed disodium injection) 7,772,209
Senju Pharm. Co., Ltd. v. Lupin Ltd., 16-1097 (D.N.J.) Feb. 26, 2016 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution) 9,144,609
Dow Pharm. Sciences, Inc. v. Actavis Labs. UT, Inc., 16-1105 (D.N.J.) Feb. 26, 2016 Hon. Stanley R. Chesler Onexton® (benzoyl peroxide / clindamycin phosphate topical gel) 8,288,434
Roxane Labs., Inc. v. Vanda Pharms., Inc., 16-0179 (S.D. Ohio) Feb. 26, 2016 Hon. Algenon L. Marbley Fanapt® (iloperidone tablets)
8,652,776
8,999,638
9,072,742
9,074,254
9,074,255
9,074,256
9,157,121
Roxane Labs., Inc. v.  Vanda Pharms. Inc., IPR2016-00690 (PTAB) Feb. 26, 2016 N/A Fanapt® (iloperidone tablets) 9,138,432
Delcor Asset Corp. v. Taro Pharm. Industries, Ltd., 16-0117 (D. Del.) Mar. 1, 2016 Hon. Gregory M. Sleet Olux-E® (clobetasol propionate topical aerosol foam)
6,730,288
7,029,659
Duchesnay Inc. v. Apotex Inc., 16-0123 Mar. 2, 2016 Hon. Sue L. Robinson Diclegis® (doxylamine succinate / pyridoxine hydrochloride delayed-release tablets) 6,340,695
Shire Development LLC v. Lupin Ltd., 16-0612 (D. Md.) Mar. 2, 2016 Hon. James K. Bredar Fosrenol® (lanthanum carbonate oral powder)
5,968,976
7,465,465
8,980,327
9,023,397
Alcon Research, Ltd. v. Watson Labs., Inc., 16-0129 (D. Del.) Mar. 4, 2016 Hon. Sue L. Robinson Ilevro® (nepafenac ophthalmic suspension)
7,947,295
8,921,337
Pernix Ireland Pain Ltd. v. Actavis Labs. FL, Inc., 16-0138 (D. Del.) Mar. 4, 2016 Hon. Gregory M. Sleet Zohydro® (hydrocodone bitartrate extended-release capsules) 9,265,760
Pernix Ireland Pain Ltd. v. Alvogen Malta Operations Ltd., 16-0139 (D. Del.) Mar. 4, 2016 Hon. Gregory M. Sleet Zohydro® (hydrocodone bitartrate extended-release capsules) 9,265,760
Takeda Gmbh v. Hetero USA Inc., 16-1280 (D.N.J.) Mar. 4, 2016 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 5,712,298
Torrent Pharms. Ltd. v. Daiichi Sankyo, Inc., 16-2988 (N. D. Ill.) Mar. 9, 2016 Hon. Rebecca R. Pallmeyer Benicar® (olmesartan medoxomil tablets) 6,878,703
Cosmo Technologies Ltd. v. Mylan Pharms. Inc., 16-0152 (D. Del.) Mar. 10, 2016 Hon. Leonard P. Stark Uceris® (budesonide tablets)
7,410,651
8,293,273
8,784,888
RE43,799
Senju Pharm. Co., Ltd. v. Innopharma Licensing, Inc., 16-1361 (D.N.J.) Mar. 10, 2016 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution) 9,144,609
Ranbaxy Inc. v. Jazz Pharms., Inc., IPR2016-00738 (PTAB) Mar. 10, 2016 N/A Xyrem® (sodium oxybate oral solution) 9,050,302
Purdue Pharma L.P. v. Actavis Labs. FL, Inc., 16-0156 (D. Del.) Mar. 11, 2016 Hon. Gregory M. Sleet Hysingla® ER (hydrocodone bitartrate extended-release tablets)
9,198,863
9,205,056
Cosmo Technologies Ltd. v. Mylan Pharms. Inc., 16-0040 (N.D.W.V.) Mar. 15, 2016 Hon. Irene M. Keeley Uceris® (budesonide tablets)
7,410,651
8,293,273
8,784,888
RE43,799
Mylan Labs. Ltd. v. Aventis Pharma S.A., IPR2016-00712 (PTAB) Mar. 15, 2016 N/A Jevtana® Kit (cabazitaxel solution for infusion) 8,927,592
Eli Lilly and Co. v. Teva Pharms. USA, Inc., 16-0596 (S.D. Ind.) Mar. 16, 2016 Hon. Tanya Walton Pratt Forteo® (teriparatide injection)
6,770,623
7,144,861
7,550,434
6,977,077
7,163,684
7,351,414
Eli Lilly and Co. v. Teva Pharms. USA, Inc., 16-0167 (D. Del.) Mar. 17, 2016 Hon. Sue L. Robinson Forteo® (teriparatide injection)
6,770,623
7,144,861
7,550,434
6,977,077
7,163,684
7,351,414
Fresenius Kabi USA, LLC v. Dr. Reddy’s Labs., Inc., 16-0169 (D. Del.) Mar. 17, 2016 Hon. Gregory M. Sleet Levothyroxine Sodium
9,006,289
9,168,238
9,168,239
Jazz Pharms., Inc. v. Watson Labs., Inc., 16-1505 (D.N.J.) Mar. 17, 2016 Hon. Esther Salas Xyrem® (sodium oxybate oral solution) 9,050,302
Amag Pharms., Inc. v. Sandoz Inc., 16-1508 (D.N.J.) Mar. 17, 2016 Hon. Peter G. Sheridan Feraheme® (ferumoxytol for injection)
6,599,498
7,553,479
7,871,597
8,501,158
8,591,864
8,926,947
BioDelivery Sciences Int’l, Inc. v. Actavis Labs. UT, Inc., 16-0175 (D. Del.) Mar. 18, 2016 Hon. Gregory M. Sleet Bunavail® (buprenorphine / naloxone buccal film)
7,579,019
8,147,866
8,703,177
Senju Pharm. Co., Ltd. v. Watson Labs., Inc., 16-1522 (D.N.J.) Mar. 18, 2016 Hon. Jerome B. Simandle Prolensa® (bromfenac ophthalmic solution) 9,144,609
Fresenius Kabi USA, LLC v. Dr. Reddy’s Labs., Inc., 16-1542 (D.N.J.) Mar. 18, 2016 Hon. Kevin McNulty Levothyroxine Sodium
9,006,289
9,168,238
9,168,239
Indivior Inc. Teva Pharms. USA, Inc., 16-0178 (D. Del.) Mar. 21, 2016 Hon. Richard G. Andrews Suboxone® (buprenorphine hydrochloride / naloxone hydrochloride sublingual film)
8,475,832
8,017,150
8,603,514
8,900,497
8,906,277
Medicis Pharm. Corp. v. Zydus Pharms. (USA) Inc., 16-1565 (D.N.J.) Mar. 21, 2016 Hon. Renee Marie Bumb Vanos® (fluocinonide topical cream)
6,765,001
7,220,424
7,794,738
8,232,264
Salix Pharms., Ltd. v. Actavis Labs. FL, Inc., 16-0188 (D. Del.) Mar. 23, 2016 Hon. Gregory M. Sleet Xifaxan® (rifaximin tablets)
6,861,053
7,045,620
7,452,857
7,605,240
7,612,199
7,718,608
7,902,206
7,906,542
7,915,275
7,935,799
8,158,644
8,158,781
8,193,196
8,309,569
8,518,949
8,642,573
8,741,904
8,829,017
8,835,452
8,853,231
8,946,252
8,969,398
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products IP Ltd., IPR2016-00777 (PTAB) Mar. 23, 2016 N/A Inomax® (nitric oxide) 8,282,966
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products IP Ltd., IPR2016-00778 (PTAB) Mar. 23, 2016 N/A Inomax® (nitric oxide) 8,431,163
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products IP Ltd., IPR2016-00779 (PTAB) Mar. 23, 2016 N/A Inomax® (nitric oxide) 8,293,284
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products IP Ltd., IPR2016-00780 (PTAB) Mar. 23, 2016 N/A Inomax® (nitric oxide) 8,795,741
Praxair Distribution, Inc. v. Mallinckrodt Hospital Products IP Ltd., IPR2016-00781 (PTAB) Mar. 23, 2016 N/A Inomax® (nitric oxide) 8,846,112
Genzyme Corp. v. Sun Pharma Global FZE, 16-1635 (D.N.J.) Mar. 24, 2016 Hon. Claire C. Cecchi Clolar® (clofarabine for injection) 5,661,136
AstraZeneca AB v. Macleods Pharms. Ltd., 16-1682 (D.N.J.) Mar. 24, 2016 Hon. Mary L. Cooper Nexium® (esomeprazole magnesium delayed-release capsules)
6,369,085
7,411,070
8,466,175
Helsinn Healthcare S.A. v. Actavis LLC, 16-1683 (D.N.J.) Mar. 24, 2016 Hon. Mary L. Cooper Aloxi® (palonosetron hydrochloride for injection)
7,947,724
9,066,980
Gilead Sciences, Inc. v. Mylan Pharms. Inc., 16-0192 (D. Del.) Mar. 25, 2016 Hon. Richard G. Andrews Tybost® (cobicistat tablets) 8,148,374
Rhodes Pharms. L.P. v. Actavis, Inc., 16-1668 (D.N.J.) Mar. 25, 2016 Hon. William H. Walls Aptensio XR® (methylphenidate hydrochloride extended-release capsules)
6,419,960
7,083,808
7,247,318
7,438,930
8,580,310
9,066,869
Alcon Research, Ltd. v. Lupin Ltd., 16-0195 (D. Del.) Mar. 28, 2016 Hon. Sue L. Robinson Pazeo® (olopatadine hydrochloride ophthalmic solution) 8,791,154
Boehringer Ingelheim Pharms. Inc. v. Sun Pharm. Industries Ltd., 16-1727 (D.N.J.) Mar. 29, 2016 Hon. Peter G. Sheridan
Tradjento® (linagliptin tablets)

Jentadueto® (linagliptin / metformin hydrochloride tablets)
9,173,859
Gilead Sciences, Inc. v. Mylan Pharms. Inc., 16-0053 (N.D.W.V.) Mar. 30, 2016 Hon. Irene M. Keeley Tybost® (cobicistat tablets) 8,148,374
Galderma Labs., L.P. v. Amneal Pharms., LLC, 16-0207 (D. Del.) Mar. 31, 2016 Hon. Leonard P. Stark Oracea® (doxycycline capsules)
7,211,267
7,232,572
8,603,506
9,241,946
7,749,532
8,206,740
8,394,405
8,394,406
8,470,364
8,709,478
Merck Sharp & Dohme Corp. v. Roxane Labs., Inc., 16-1804 (D.N.J.) Mar. 31, 2016 Hon. Peter G. Sheridan Noxafil® (posaconazole oral suspension)
5,661,151
6,958,337
United Therapeutics Corp. v. Actavis Labs. FL, Inc., 16-1816 (D.N.J.) Mar. 31, 2016 Hon. Peter G. Sheridan Orenitram® (treprostinil extended-release tablets)
7,417,070
7,544,713
8,252,839
8,349,892
8,410,169
8,497,393
9,050,311
8,747,897
9,278,910

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.